DK0531845T3 - Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester - Google Patents

Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester

Info

Publication number
DK0531845T3
DK0531845T3 DK92114835.9T DK92114835T DK0531845T3 DK 0531845 T3 DK0531845 T3 DK 0531845T3 DK 92114835 T DK92114835 T DK 92114835T DK 0531845 T3 DK0531845 T3 DK 0531845T3
Authority
DK
Denmark
Prior art keywords
methoxyethyl
nitrophenyl
dihydro
dimethyl
pharmaceutical compositions
Prior art date
Application number
DK92114835.9T
Other languages
English (en)
Inventor
Alfons Dr Grunenberg
Ahmed Dr Hegasy
Wolfgang Dr Mueck
Gerhard Dr Franckowiak
Rango-Rao Dr Kanikanti
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0531845T3 publication Critical patent/DK0531845T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
DK92114835.9T 1991-09-11 1992-08-31 Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester DK0531845T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4130173A DE4130173A1 (de) 1991-09-11 1991-09-11 Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters

Publications (1)

Publication Number Publication Date
DK0531845T3 true DK0531845T3 (da) 1996-11-25

Family

ID=6440342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92114835.9T DK0531845T3 (da) 1991-09-11 1992-08-31 Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester

Country Status (11)

Country Link
US (1) US5599824A (da)
EP (1) EP0531845B1 (da)
JP (1) JPH05229945A (da)
AT (1) ATE141052T1 (da)
CA (1) CA2077704C (da)
DE (2) DE4130173A1 (da)
DK (1) DK0531845T3 (da)
ES (1) ES2090432T3 (da)
GR (1) GR3020962T3 (da)
HK (1) HK41697A (da)
MX (1) MX9205077A (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
AU2004246870B2 (en) 2003-06-13 2009-07-23 Skendi Finance Ltd Slow release estradiol-progesterone formulation for contraception and hormone replacement therapy
CN1824647B (zh) * 2005-02-22 2011-04-20 田边三菱制药株式会社 (±)2-(二甲基氨基)-1-{[O-(m-甲氧基苯乙基)苯氧基]甲基}乙基氢琥珀酸酯盐酸盐的晶体
US9399019B2 (en) 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
US20180098977A1 (en) * 2016-08-23 2018-04-12 Edge Therapeutics, Inc. Scalable microparticulate formulations containing polymorphic nimodipine form 2 prepared by a solvent evaporation process
WO2019018306A1 (en) * 2017-07-17 2019-01-24 Edge Therapeutics, Inc. ADVANCED MICROPARTICULAR FORMULATIONS CONTAINING FORM 2 OF MICRONIZED POLYMORPHIC NIMODIPINE
USD867911S1 (en) * 2018-10-10 2019-11-26 Adel J M S Alabdin Combination gas leak sensor and communication device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932645A (en) * 1971-04-10 1976-01-13 Farbenfabriken Bayer Ag Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
DE3424553A1 (de) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
GB8729471D0 (en) * 1987-12-17 1988-02-03 Wyeth John & Brother Ltd New crystal form

Also Published As

Publication number Publication date
DE4130173A1 (de) 1993-03-18
CA2077704A1 (en) 1993-03-12
JPH05229945A (ja) 1993-09-07
DE59206868D1 (de) 1996-09-12
CA2077704C (en) 2003-03-11
ES2090432T3 (es) 1996-10-16
US5599824A (en) 1997-02-04
EP0531845B1 (de) 1996-08-07
HK41697A (en) 1997-04-11
GR3020962T3 (en) 1996-12-31
ATE141052T1 (de) 1996-08-15
MX9205077A (es) 1993-03-01
EP0531845A1 (de) 1993-03-17

Similar Documents

Publication Publication Date Title
UA6344A1 (uk) Спосіб одержання бензолсульфонатної солі 3-етіл-5метілового ефіру 2-(2-аміноетоксіметіл)-4-(2-хлорфеніл)-6-метіл-1,4-дігідропірідін-3,5-дікарбонової кислоти
DK63085D0 (da) Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre
JPS55301A (en) 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
MX9205215A (es) Procedimiento novedoso para la preparacion de 1,4-dihidropiridina 4-substituida
MX9708662A (es) Un procedimiento para la preparacion de clorhidrato de lercanidipino.
AU557175B2 (en) 2,6-dimethyl-4-(3-nitro phenyl)-1,4-dihydro pyridine-3,5- dicarboxylic acid esters
DK0531845T3 (da) Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester
UA27719C2 (uk) Ефіри 2,6-диметил-1,4-дигідропіридин-3-карбонової кислоти, що є блокаторами кальцієвих каналів, спосіб їх одержання та фармацевтична композиція
SE433211B (sv) Analogiforfarande for framstellning av 1,4-dehydro-2,6-dimetyl-4-(3-nitrofenyl)-3,5-pyridindikarbonsyra-isopropyl-(2-propoxietyl)-ester
GR890100133A (el) Μεθοδος παρασκευης παραγωγων 1,4 διυδροπυριδινης.
EP0207674A3 (en) 1,4-dihydropyridine derivatives, their preparation and their pharmaceutical use
EP0445987A3 (en) Novel process for producing 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate-3-methyl ester-5-beta-(n-benzyl-n-methylamino)ethyl ester
DK166386C (da) Diastereoisomer a af 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)ester-5-methylester, den hoejredrejende optiske isomer heraf, fremgangsmaader til fremstilling af forbindelserne og farmaceutiske praeparater indeholdende disse
PT84566B (pt) Processo para a preparacao do novo composto com actividade optica (+)-1,4- -dihidro-2,6-dimetil-4-(3-nitrofenil)-piridina-3,5-dicarboxilato de 3-metil-5- -{3-(4,4-difenil-piperidil-1)-profilo} e de composicoes farmaceuticas que o contem
IL104357A0 (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it
DK468385A (da) Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester
ATE126190T1 (de) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-
EP0167068A3 (en) Isopropyl-2û2-(3-trifluoromethylphenoxy)ethyl¨ester of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylic acid, process for its preparation, and its use as a medicine
RU1828464C (ru) Способ получени диметилового эфира 1,4-дигидро-2,6-диметил-4-/2 @ -нитрофенил/-пиридин-3,5-дикарбоновой кислоты
LV5619A3 (lv) Panemiens 2-(2-aminoetoksimetil)-4-(2-hlorfenil)-6-metil-1,4-dihidropiridina-3,5-dikarbonskabes 3-etil-5-metilestera benzolsulfoskabes sais iegusanai
YU188386A (en) Process for obtaining asymmetric diesthers of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylic acid
AU626404B2 (en) A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester
YU66687A (en) Process for obtaining hydrochloride of 2(n-benzyl-n-m-ethylamino)-ethyl-methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridin-dicarboxilate
IL81998A (en) Optically active 3-methyl-5-(3-(4,4-diphenylpiperid-1-yl)-propyl)-(+)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate and its salts,processes for the preparation thereof and pharmaceutical compositions containing the same
IL106369A0 (en) A specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it